INTRODUCTION
============

Borderline personality disorder (BPD) is characterized by "stable instability" ([@B54]) of emotions, impulsivity, social relationships, and self-image. Additionally most patients suffer from chronic feelings of emptiness, complex dissociations, self-injury, and suicidal tendencies with a suicide rate of 10% ([@B51]). BPD, which often co-occurs with other psychiatric disorders (about 85% of patients with BPD fulfill criteria for having at least one Axis I disorder; [@B41]), is common with a prevalence of more than 20% for psychiatric inpatients ([@B63]). Behavioral and emotional dysregulation is suggested as critical factors underlying this variety of symptoms ([@B40]). We suggest that the stability of fluctuating symptoms across time and different situations might be related to consistent and profound functional alterations in the patient's brain intrinsic functional architecture, particularly in brain regions involved in behavior/emotion regulation.

Previous functional neuroimaging studies revealed context specific patterns of altered brain activity in BPD patients during emotion- or self-related tasks. For example, negative emotional pictures or fearful/angry faces evoke stronger activity in the extrastriate, posterior cingulate, and frontal cortices, as well as weaker activity in the amygdala ([@B49]; [@B35]; [@B50]; [@B27]). In healthy subjects, self-distancing of negative pictures activates parietal regions overlapping with the so-called default mode network (DMN) including the medial prefrontal, medial and lateral parietal cortex ([@B36]). Patients with BPD, however, fail to activate the DMN but show increased activity in the amygdala. On the contrary, memories of unresolved life events activate regions of the DMN in addition to amygdala, insula, and occipital cortices in patients ([@B6]). Overall, emotional and self-related context increasingly activates an aberrant distributed pattern of brain regions including the DMN, insula, amygdala, and occipital cortices in BPD patients.

The measure of intrinsic functional connectivity (iFC), i.e., coherence of ongoing blood-oxygenation-level-dependent (BOLD) signal fluctuations in resting-state functional magnetic resonance imaging (rs-fMRI) data, is a surrogate for organized intrinsic brain activity ([@B19]). At a large-scale level, coherent BOLD activity across remote brain areas forms consistent intrinsic connectivity networks (ICNs) in humans ([@B12]). Importantly, ICNs show strong spatial correspondence in independent analyses of resting-state and task-related activity patterns ([@B58]; [@B37]), suggesting that certain intrinsically coupled functional networks are also systematically engaged during cognition and behavior. Moreover, direct evidence exists that ongoing activity in ICNs serves as a scaffold for patterns of evoked neuronal activity ([@B32]), supporting the idea that the intrinsic architecture maintains and updates the brain's repertoire of functional responses.

A recently proposed neurocognitive framework identified ICNs related to self-, emotion-, and cognitive control processing as neurocognitive "core" networks to study higher cognitive function and dysfunction ([@B47]; [@B46]). In more detail, the anterior and posterior DMN (a/pDMN) covering the medial prefrontal cortex (mPFC), posterior cingulate cortex (PCC), and precuneus consistently activate during self-related and social cognitive functions ([@B9]; [@B5]). The salience network (SN) covers anterior and posterior parts of the insula (AI, PI) and the anterior cingulate cortex (ACC) is critically involved in emotions, pain, and interoception ([@B55]; [@B62]; [@B39]). Finally, left and right lateralized fronto-parietal networks (central executive network, CEN) are robustly associated with cognitive and executive control processes during goal-directed behavior ([@B55]; [@B13]; [@B23]). The consistent involvement of these three networks does not exclude other areas or networks to be also relevant for these functions particularly in specific contexts. However, it seems that these networks critically contribute (like a "core") to self-, emotion-, and cognitive control-related processes ([@B46]), which are impaired in patients with BPD.

Several studies reported aberrant iFC within and across these ICNs in various neuropsychiatric diseases such as major depression (MD) or schizophrenia ([@B22]; [@B25]; [@B64]; [@B43],[@B44]) indicating the large-scale brain impact of these diseases on basic intrinsic functional network architecture and associated functions (for review, see also [@B46]; [@B52]; [@B24]). Due to both the persistent nature of BPD and its "stable instability" in emotion-, self-, and control-related functions, we suggest altered iFC among DMN, SN, and CEN in BPD. In the so far only previous study focusing on iFC in BPD, [@B66] found aberrant (i.e., increased and decreased) iFC within the DMN and CEN of patients with BPD; but this did not yield information about the SN and the intrinsic connectivity across networks. To test our hypothesis about aberrant iFC within and across SN, DMN, and CEN in BPD, we acquired rs-fMRI data from patients with BPD and matched healthy controls (HC). We applied data-driven, high-model-order independent component analysis (ICA) to the rs-fMRI data to extract ICNs of coherent ongoing BOLD activity ([@B11]; [@B3]). We then examined the relationship, i.e., iFC, within (intra-iFC) and between (inter-iFC) ICNs-of-interest and provide a new measure capturing the balance across these neurocognitive networks.

MATERIALS AND METHODS {#s1}
=====================

SUBJECTS
--------

Fourteen right-handed patients and 16 age-, sex-, and handedness-matched HC participated in the study after signing the informed consent form in accordance with the Human Research Committee guidelines of the Klinikum Rechts der Isar, Technische Universität München (**Table [1](#T1){ref-type="table"}**). Patients were recruited from the Department of Psychiatry, Klinikum rechts der Isar, Technische Universität München. Controls were recruited by word-of-mouth advertising from the larger Munich area. Participants' examination included medical history, psychometric assessments \[i.e., Beck Depression Inventory (BDI; [@B7]), Hamilton Depression Scale (HDS; [@B26]), short version of the Borderline Symptom List (BSL; [@B8]), and Global Assessment of Functioning (GAF) Scale ([@B15])\] and a structured psychiatric interview for patients only \[Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I; [@B18]) and Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II; [@B17]), German version\]. All participants were examined by their psychiatrists (Andreas Wöller, Christian Sorg), professionally trained for SCID-based interviews with an inter-rater reliability of more than 95%. Psychiatric diagnoses were based on Diagnostic and Statistical Manual of Mental Disorders-IV (DSM IV).

###### 

Demographics and psychometric scores.

  Parameter          Patients with BPD                         HC
  ------------------ ----------------------------------------- ------------
  *n*                14                                        16
  Age (year)         30.4                                      34.0
  Sex, male/female   1/13                                      1/15
  GAF                43.7 ± 9.1^[\*](#fn04){ref-type="fn"}^    100 ± 0
  HDS                17.1 ± 7.4^[\*](#fn04){ref-type="fn"}^    0.5 ± 0.8
  BDI                18.1 ± 15.4^[\*](#fn04){ref-type="fn"}^   1.8 ± 2.7
  BSL                51.0 ± 17.4^[\*](#fn04){ref-type="fn"}^   10.9 ± 3.9

Data are presented as mean ± SD. HC, healthy controls; BPD, borderline personality disorder; GAF, Global Assessment of Functioning, HDS, Hamilton Depression Scale; BDI, Beck Depression Inventory; BSL, Borderline Symptom List;

*p* \< 0.05 (two-sample *t*-tests).

Patients with BPD constitute a heterogeneous group of patients, who vary in diagnostic subcategories (e.g., with/without feeling of emptiness or stress-related paranoid ideation), comorbidity (e.g., with/without MD or post-traumatic stress disorder, PTSD), and degree of medication (e.g., with/without neuroleptica; [@B56]). We adopted selection criteria for a representative group of patients recommended by [@B57] based on a longitudinal examination of 240 patients with BPD. BPD was the primary diagnosis for all patients. We excluded patients with current psychosis, intoxication, or confusional states, with a history of schizophrenia, schizoaffective disorder or bipolar disorder but we allowed co-occurrence of Axis I disorders MD or PTSD and psychotropic medication ([@B57]). Additional exclusion criteria were an age below 18 or above 60 years, pregnancy, neurological or internal systemic diseases, and general contraindications for MRI assessment. A detailed description of each patient's current comorbidity and medication can be found in **Table [2](#T2){ref-type="table"}**. All control subjects were free of any current or past neurological or psychiatric disorder or psychotropic medication.

###### 

Detailed clinical characteristics of patients with BPD.

  Patients   Medication                                                           Current comorbidity                                              History of comorbidity
  ---------- -------------------------------------------------------------------- ---------------------------------------------------------------- ---------------------------------
  1          Quetiapine 50 mg, Fluoxetine 20 mg                                   PTSD                                                             Substance abuse
  2          Olanzapine 5 mg, Quetiapine 600 mg (prolong), Escitalopram 20 mg     Alcohol abuse                                                    MDD
  3          Escitalopram 20 mg, Zopiclone 7.5 mg                                 Bulimia nervosa                                                  Recurrent MDD
  4          Quetiapine 100 mg, Lamotrigine 12.5 mg                               Substance abuse, Cannabis dependence                             Recurrent MDD
  5          Quetiapine 300 mg (prolong), Sertraline 150 mg, Aripiprazole 10 mg   Multiple personality disorders                                   None
  6          None                                                                 None                                                             None
  7          Atomoxetine 50 mg, Fluoxetine 20 mg, Paliperidone 3 mg               MDD, ADHD, alcohol abuse                                         Anorexia nervosa, recurrent MDD
  8          Fluoxetine 40 mg                                                     MDD                                                              Substance abuse
  9          Fluoxetine 30 mg, Quetiapine 12.5 mg, Pregabalin 225 mg              Undifferentiated somatoform disorder, alcohol abuse              Alcohol abuse
  10         Aripiprazole 20 mg, Venlafaxine 150 mg                               Alcohol abuse                                                    Alcohol abuse
  11         Pregabalin 300 mg, Quetiapine 60 mg, Venlafaxine 225 mg              PTSD, undifferentiated somatoform disorder, alcohol dependence   Recurrent MDD
  12         None                                                                 None                                                             None
  13         Sertraline 75 mg                                                     PTSD, substance abuse                                            Recurrent MDD
  14         Sertraline 50 mg                                                     Cannabis abuse                                                   Recurrent MDD

BPD, borderline personality disorder; PTSD, post-traumatic stress disorder; MDD, major depressive disorder.

All participants in this study underwent 10 min of rs-fMRI with the instruction to keep their eyes closed and not to fall asleep. We verified that subjects stayed awake by interrogating via intercom immediately after the rs-fMRI scan. Before and after scanning, a medical examination of patients validated their stable condition and investigated whether they had feelings of odd situations during the scanning. No patient dropped out during the scanning session.

MRI DATA ACQUISITION
--------------------

Magnetic resonance imaging was performed on a 3-T whole body MR scanner (Achieva, Philips, Netherlands) using an eight-channel phased-array head coil. For co-registration of functional data, T1-weighted anatomical data were obtained from each subject by using a magnetization-prepared rapid acquisition gradient echo sequence \[time to echo (TE) = 4 ms, repetition time (TR) = 9 ms, time for inversion (TI) = 100 ms, flip angle = 5°, field of view (FoV) = 240 mm × 240 mm, matrix = 240 × 240, 170 slices, voxel size = 1 mm × 1 mm × 1 mm\]. fMRI data were collected using a gradient echo planar imaging (EPI) sequence (TE = 35 ms, TR = 2000 ms, flip angle = 82°, FoV = 220 mm × 220 mm, matrix = 80 × 80, 32 slices, slice thickness = 4 mm, and 0 mm interslice gap; an fMRI run of 10 min results in 300 volumes).

fMRI DATA ANALYSIS
------------------

### Preprocessing

For each participant the first three functional scans of each fMRI-session were discarded due to magnetization effects. SPM5^[1](#fn01){ref-type="fn"}^ (Wellcome Department of Cognitive Neurology, London) was used for motion correction, spatial normalization into the stereotactic space of the Montreal Neurological Institute (MNI) with resampling of voxel size to 3 mm × 3 mm × 3 mm, and spatial smoothing by applying an 8 mm × 8 mm × 8 mm Gaussian kernel. None of the participants had to be excluded due to excessive head motion (linear shift \<3 mm across run and on a frame-to-frame basis, rotation \<1.5°). Two-sample *t*-tests between groups yielded no significant results regarding translational and rotational movements of any direction as well as voxel-wise signal-to-noise ratio of fMRI data calculated with DPARSFA toolbox^[2](#fn02){ref-type="fn"}^ (*p* \< 0.05).

### Independent component analysis of fMRI data

Following a recent approach ([@B44]), we applied high-model-order ICA to the preprocessed data by using the Group ICA of fMRI Toolbox (GIFT)-toolbox^[3](#fn03){ref-type="fn"}^ (version 1.3h) with the infomax algorithm implemented in Matlab ([@B11]). Data were decomposed into 70 spatial independent components (ICs), correspondent with a recently suggested framework for high-model-order decomposition ([@B1]; [@B3]). High-model-order ICA approaches yield ICs, which are in accordance with large-scale functional networks from low-order approaches but offer a more detailed and particularly robust decomposition of sub-networks ([@B12]; [@B34]; [@B58]). Before volumes were entered into ICA analysis, voxel-wise *z*-transformation on time course data *y~ijk~*(*t*) was applied by subtracting the mean 〈*y~ijk~*〉 and dividing by the standard deviation σ*~ijk~ {ŷ~ijk~(t) = \[y~ijk~(t) - 〈y~ijk~〉\]/σ~ijk~*}, *t* time, *i,j,k* directions in space; [@B61]). The sensitivity of the multivariate ICA algorithm for correlation of variance between voxels, i.e., functional connectivity, was thereby rendered independent of the original BOLD signal magnitude across subjects. Data were concatenated and reduced by two-step principal component analysis (PCA), followed by IC estimation with the infomax algorithm. We subsequently ran 40 ICAs (ICASSO) to ensure stability of the estimated components ([@B29]). This results in a set of average group components, which are then back reconstructed into single subject space employing a dual regression analysis (group ICA (GICA) back-reconstruction approach (GICA-3) in GIFT; [@B16]). Each thus reconstructed IC results in a spatial map of *z*-scores reflecting the within-network iFC (intra-iFC) of a voxel within this component and an associated time course of BOLD signal fluctuations representative for this IC. We then reintegrated the initially calculated scaling factor σ*~ijk~* into the data by voxel-wise multiplication in order to preserve each individual's profile of variance magnitude while leaving the normalized time course component unchanged.

### Network selection

As previously described ([@B44]), we ran a multiple spatial regression with a previously established baseline set of functionally relevant ICNs as regressors of interest ([@B3]) to automatically identify DMN, SN, and CEN in our dataset. From this publication, we selected the posterior (IC 53) and anterior (IC 25) DMN (a/pDMN), left and right lateralized fronto-parietal networks (ICs 34 and 60) reflecting left and right CEN, and an insular network (IC 55) reflecting the SN. The template for the insular network revealed a second component covering PI and bilateral amygdala and hippocampus \[which we called posterior SN (pSN) in contrast to the anterior SN (aSN); see also [@B55]; [@B62]; [@B39]\]. Due to the importance of insular structures in BPD we also selected this component for further analyses.

### Statistical analysis

To evaluate the spatial consistency of ICNs (intra-iFC), we calculated voxel-wise one-sample *t*-tests on participants' reconstructed spatial maps using SPM5 for each ICN and group (*p* \< 0.05, corrected for false discovery rate, FDR). We then examined group differences of intra-iFC. The individual *z*-maps were entered into voxel-wise two-sample *t*-tests and a conjunction map of the one-sample *t*-test image (*p* \< 0.001 uncorrected) was applied as a mask to the analysis. In order to control for antipsychotic medication we added chlorpromazine (CPZ)-equivalent doses ([@B67]) as covariate-of-no-interest in all imaging analyses. The resulting SPMs were thresholded at *p* \< 0.001 (voxel level) and *p* \< 0.05 \[corrected for family wise error (FWE) at cluster level\].

In order to investigate group effects of inter-iFC *between* ICNs, we extracted each subject's IC-timecourse of a/pDMN, l/r CEN, and a/pSN, calculated pairwise Pearson's correlation coefficients between the time course of all ICNs for each subject, transformed the correlation matrix into *z*-values via Fisher *r*-to-*z*-transformation and tested differences between the two groups (two-sample *t*-tests with CPZ as covariate-of-no-interest, *p* \< 0.05, Bonferroni-corrected for 15 pairwise correlations).

### CEN/SN-inter-iFC index

Finally, we calculated the ratio (*r*) of overall inter-iFC for SN and CEN within the intrinsic functional architecture of DMN, SN, and CEN for each group controlling for effects of antipsychotic medication (two-sample *t*-test, *p* \< 0.05): *r* = inter-iFC~sum~(CEN)/inter-iFC~sum~(SN). Here, the inter-iFC~sum~ reflects the inter-network connectivity of CEN and SN, and is calculated as the summarized absolute *z*-values of each network from the between ICN analysis. This integrated score is motivated by the idea that both SN and CEN interact with the DMN and among each other during emotion regulation, and that they are involved in cognitive control processes (task-positive networks; [@B55]) with stronger representation of motivational/emotional aspects by the SN and of attention-related aspects by the CEN ([@B13]; [@B46]; [@B24]).

RESULTS
=======

Psychometric assessment revealed significant differences between patients and controls for GAF (two-sample *t*-test, *t* = 17.3, *p* \< 0.05), HDS (*t* = -7.1, *p* \< 0.05), BDI (*t* = -3.1, *p* \< 0.05), and BSL (*t* = -5.8, *p* \< 0.05) between the two groups (**Table [1](#T1){ref-type="table"}**).

INTRA-iFC
---------

Automated component selection, which was based on spatial templates representing subsystems of the DMN, SN, and CEN (see Figure 4 in [@B3] for spatial templates), revealed six IC of interest from high-model-order analysis of fMRI data for each individual. The SN was represented in an anterior and posterior insular network (a/pSN), the DMN in an a/pDMN, and the CEN in left and right (l/r) CEN. Selected components were spatially consistent across groups and matched previous results of SN, DMN, and CEN ([@B3]; see **Figure [1](#F1){ref-type="fig"}** and **Table [3](#T3){ref-type="table"}** for detailed description of intra-iFC within selected ICNs, *p* \< 0.05, FDR-corrected).

![**Spatial maps and time courses of default mode, salience, and central executive network (DMN, SN, CEN) in healthy controls and patients.** Spatial statistical parametric maps (SPM, one-sample *t*-tests controlled for medication) and associated time courses of intrinsic networks in healthy controls (HC) and patients with borderline personality disorder (BPD). Maps and time courses are derived from independent component analysis of resting-state fMRI of subjects. SPMs are thresholded at *p* \< 0.05 FDR-corrected and superimposed on a single subject high resolution T1 image. Color coding (red \> yellow) represents *t*-values ranging from 3 to 25. The *x*-axis of signal time courses reflects number of fMRI scans; the *y*-axis represents normalized signal amplitude. First to third row: anterior and posterior (a/p) DMN, anterior and posterior SN, left and right (l/r) CEN.](fnhum-07-00727-g001){#F1}

###### 

Spatial intra-iFC maps of DMN, SN, and CEN in controls and patients.

  Networks and brain regions              HC     BPD                                                  
  --------------------------------------- ------ ------- ----- ----- ----- ------ ------- ----- ----- -----
  **aDMN**                                                                                            
  Superior frontal gyrus                  2506   18.39   15    63    21    1460   14.39   -6    54    15
  Anterior cingulate cortex                      17.68   6     48    21           12.18   -3    60    30
  Inferior frontal gyrus                                                   63     6.24    -45   33    -12
  Middle cingulate cortex                 56     4.8     0     -3    30                               
  Posterior cingulate cortex, precuneus   195    6.78    0     -60   27    330    12.9    -3    -51   33
  Angular gyrus                                                            266    10.91   -51   -66   30
  Precentral sulcus                       54     6.5     -6    -36   66                               
  Cerebellum                              155    10.11   12    -54   -42   43     5.12    6     -54   -42
  Putamen                                                                  25     5.41    -21   6     12
  Middle occipital gyrus                                                   74     5.08    57    -63   24
  **pDMN**                                                                                            
  Posterior cingulate cortex              2749   17.13   3     -48   21    4122   26.56   12    -48   30
  Precuneus                                                                       22.45   -9    -57   33
  Angular gyrus                           247    15.48   45    -51   27                               
  Anterior cingulate cortex                                                39     3.87    6     39    21
  Middle temporal gyrus                   34     5.69    60    0     -21   79     4.87    -57   3     -24
  Hippocampus                                                              40     6.71    24    -36   -3
  Cerebellum                                                               47     4.12    -3    -24   -21
  Fusiform gyrus                                                           42     3.62    36    -75   -3
  **aSN**                                                                                             
  Right anterior insula                   882    18.58   39    18    -3    723    18.88   48    24    -3
  Left anterior insula                    696    12.84   -33   9     -6    631    12.78   -30   27    -6
  Orbitofrontal gyrus                                                      53     4.94    -30   51    -3
  Anterior cingulate cortex               275    6.41    9     39    15    868    8.19    -9    48    18
  Superior medial gyrus                                                                               
  Middle cingulate cortex                 81     6.39    -6    -36   45           9.32    9     24    33
  Thalamus                                138    7.46    -9    -21   6     14     4.86    -9    -9    9
  Cerebellar vermis                       53     6.33    9     -57   -30                              
  Middle frontal gyrus                    37     5.02    33    51    12           12.78   -39   27    -6
  Angular gyrus                           150    6.31    48    -45   30                               
  **pSN**                                                                                             
  Right posterior insula                  1239   11.6    48    9     0     679    14.82   51    -3    -12
  Left posterior insula                   892    11.03   -45   -12   3     487    11.96   -51   0     -6
  Hippocampus                             989    13.07   -15   -30   -6                               
  Anterior cingulate cortex               298    7.03    0     36    9     111    8.32    0     36    9
  Inferior frontal gyrus                  85     5.37    -48   30    15    50     5.91    -54   33    3
  Right Amygdala                          31     4.02    24    -3    -15                              
  **lCEN**                                                                                            
  Middle frontal gyrus                    1229   13.95   -24   23    59    2580   14.51   -45   36    18
  Superior frontal gyrus                         10.09   -15   36    51                               
  Inferior frontal gyrus                                                   277    10.05   48    36    21
  Superior medial gyrus                   181    7.25    0     63    0                                
  Middle orbital gyrus                    47     5.44    -42   48    -3                               
  Middle cingulate cortex                 388    8.86    0     -36   36                               
  Thalamus                                                                 62     5.95    -6    -15   12
  Inferior parietal lobe                  128    6.52    48    -60   27    2071   14.46   -27   -66   39
                                                                                  13.49   -48   -42   48
  Superior temporal gyrus                                                  45     4.86    66    -15   6
  Insula                                                                   66     4.27    42    0     6
  Hippocampus                                                              44     6.5     -15   -3    -21
  Cerebellum                              298    7.78    39    -75   -30   293    8.35    30    -66   -33
  Superior occipital gyrus                                                 255    8.13    33    -72   45
  **rCEN**                                                                                            
  Middle frontal gyrus                    1271   11.93   39    18    54    757    10.64   39    21    42
  Middle orbital gyrus                    54     4.92    -39   48    -9    220    8.54    36    51    -12
  Middle cingulate cortex                 85     7.68    3     -39   39    155    7.51    6     -45   33
  Middle temporal gyrus                   46     5.91    69    -42   0                                
  Inferior parietal lobule                641    19.16   -51   -54   45    665    10.65   -48   -54   48
  Angular gyrus                           1047   19.2    42    -60   39    967    20.56   42    -63   42
  Precuneus                                                                133    7.65    6     -78   42
  Cerebellum                              210    9.39    -36   -66   -42   124    7       -30   -66   -36
  Fusiform gyrus                                                           83     4.57    30    -66   -9

One-sample

t

-test (corrected for medication),

p

\< 0.05 corrected for false discovery rate. HC, healthy controls; BPD, borderline personality disorder; aDMN, pDMN, anterior and posterior default mode network; aSN, pSN, anterior and posterior salience network; lCEN, rCEN, left and right central executive network. Coordinates are presented in MNI standard space.

Group comparisons of networks' intra-iFC revealed regionally increased intra-iFC in each ICN of patients and decreased intra-iFC in only two ICNs (i.e., pSN, lCEN; *p* \< 0.05 FWE-corrected cluster level and Bonferroni-corrected for six ICNs; **Figure [2](#F2){ref-type="fig"}**; **Table [4](#T4){ref-type="table"}**). Increased intra-iFC in the BPD group covered various brain regions (*midline structures*: ACC, PCC, medial frontal gyrus; *parietal lobe*: bilateral SPL; *insula*: posterior part), decreased intra-iFC occurred in right hippocampus and left superior frontal gyrus.

![**Aberrant intrinsic functional connectivity within DMN, SN, and CEN (intra-iFC) of patients.** SPMs of group differences in intra-iFC for the DMN, SN, and CEN (voxel-wise two-sample *t*-tests) controlled for antipsychotic medication. SPMs are thresholded at *p* \< 0.05, FWE-corrected at cluster level and superimposed on a single subject high resolution T1 image. Color coding (red \> yellow) represents *t*-values ranging from 4 to 11.](fnhum-07-00727-g002){#F2}

###### 

Group differences of intra-iFC maps for DMN, SN, and CEN.

  Network with brain region                         HC   BPD                                                
  ------------------------------------------------- ---- ------ ----- ----- ----- ----- ------ ----- ------ ----
  **aDMN**                                                                                                  
  Left superior medial frontal gyrus                                              108   7.35   -9    57     24
  Left superior frontal gyrus                                                           3.92   -12   51     33
  Intraparietal junction                                                          55    3.42   -51   -63    33
  **pDMN**                                                                                                  
  Left precuneus                                                                  207   6.67   -3    -63    24
  **aSN**                                                                                                   
  Left superior medial gyrus                                                      111   5.13   -9    48     18
  Left anterior cingulate gyrus                                                         4.15   -3    45     9
  Right anterior cingulate gyrus                                                        4.07   6     45     12
  **pSN**                                                                                                   
  Right insular lobe                                                              186   5.64   48    6      -6
  Right hippocampus                                 38   4.45   21    -30   -12                             
  **lCEN**                                                                                                  
  Left precentral gyrus                                                           639   8.12   -45   12     30
  Left inferior frontal gyrus (pars triangularis)                                       7.77   -42   3021   
  Left inferior parietal lobule                                                   398   9.06   -45   -45    51
  Left middle temporal gyrus                                                      47    5.51   -57   -54    0
  Left superior frontal gyrus                       85   5.21   -15   36    51                              
  **rCEN**                                                                                                  
  Right angular gyrus                                                             168   5.49   54    -48    30
  Right inferior parietal lobule                                                        4.54   45    -51    39

Two-sample

t

-test (corrected for medication),

p

\< 0.05 corrected for family wise error at cluster level and Bonferroni-corrected for six comparisons; green indicates increased intra-iFC in patients, red reduced intra-iFC. HC, healthy controls; BPD, borderline personality disorder; aDMN, pDMN, anterior and posterior default mode network; aSN, pSN, anterior and posterior salience network; lCEN, rCEN, left and right central executive network. Coordinates are presented in MNI standard space.

INTER-iFC
---------

To explore inter-iFC across DMN, SN, and CEN, we calculated the pairwise correlation between network time courses and tested significance of correlations and their potential group differences by using one- and two-sample *t*-tests controlling for effects of medication (CPZ covariate-of-no-interest). In HC, we found significant inter-iFC for 9 of 15 network pairs, while only four significant correlations occurred in BPD (*p* \< 0.05, Bonferroni-corrected, black lines in **Figure [3A](#F3){ref-type="fig"}**; **Table [5](#T5){ref-type="table"}**). The analysis of group differences revealed specific changes in the intrinsic functional architecture of patients (*p* \< 0.05, Bonferroni-corrected for 15 connections; **Table [5](#T5){ref-type="table"}**). More specifically, absent inter-network connectivity was found mainly for interactions concerning the CEN where four of six connections significantly decreased. Contrary to this overall decrease of iFC in patients, two additional intrinsic inter-network connections occurred in the patients group for the SN (red lines in **Figure [3A](#F3){ref-type="fig"}**).

![**Aberrant intrinsic functional connectivity between DMN, SN, and CEN (inter-iFC) of patients.** **(A)** Inter-iFC between two networks is based on Pearson's correlation between network time courses. In healthy controls (HC), black lines indicate significant inter-iFC (one-sample *t*-tests, *p* \< 0.05, Bonferroni-corrected for 15 correlations). Thickness of lines reflects absolute values of Fisher-*z*-normalized correlation coefficients. In patients with BPD, red lines indicate increased inter-iFC compared to healthy controls, while missing lines indicate significantly reduced and absent connections in BPD (two-sample *t*-tests, *p* \< 0.05, Bonferroni-corrected). See also **Table [5](#T5){ref-type="table"}** for correlation coefficients of significant inter-iFC. Results are controlled for antipsychotic medication. **(B)** For each subject, the ratio (*r*) of overall inter-iFC for CEN and SN within the intrinsic functional architecture of DMN, SN, and CEN was calculated by *r* = inter-iFC~sum~(CEN)/inter-iFC~sum~(SN), with inter-iFC~sum~ for CEN and SN, respectively, reflecting summarized absolute *z*-values of inter-iFC. We found significantly reduced *r* in patients (two-sample *t*-test, \*\**p* = 0.007).](fnhum-07-00727-g003){#F3}

###### 

Inter-iFC between DMN, SN, and CEN.

  Inter-iFC between ICNs   Healthy controls   BPD patients   Two-sample *t*-test (*p*)                                
  ------------------------ ------------------ -------------- --------------------------- ------- -------- ----------- -----------
  aDMN--aSN                0.083              -0.089         0.300                       0.112   0.144    0.220       0.177
  aDMN--lCEN               0.059              0.472          0.000\*\*                   0.059   -0.036   0.550       0.000\*\*
  aDMN--pDMN               0.077              0.391          0.000\*\*                   0.086   0.417    0.000\*\*   0.887
  aDMN--pSN                0.067              0.361          0.000\*\*                   0.073   -0.063   0.406       0.000\*\*
  aDMN--rCEN               0.075              0.348          0.000\*\*                   0.086   0.262    0.010\*     0.574
  aSN--lCEN                0.089              -0.392         0.001\*\*                   0.079   0.014    0.860       0.003\*\*
  aSN--pSN                 0.056              0.041          0.472                       0.075   0.372    0.000\*\*   0.009\*\*
  aSN--rCEN                0.084              -0.150         0.095                       0.118   -0.017   0.889       0.323
  lCEN--pDMN               0.064              0.563          0.000\*\*                   0.062   -0.112   0.095       0.000\*\*
  lCEN--pSN                0.090              -0.057         0.534                       0.052   -0.035   0.507       0.783
  lCEN--rCEN               0.112              0.236          0.053                       0.097   0.056    0.574       0.220
  pDMN--aSN                0.061              -0.347         0.000\*\*                   0.081   -0.236   0.012\*     0.461
  pDMN--pSN                0.082              -0.019         0.824                       0.076   -0.446   0.000\*\*   0.003\*\*
  pDMN--rCEN               0.083              0.354          0.001\*\*                   0.093   0.437    0.000\*\*   0.672
  rCEN--pSN                0.077              0.354          0.000\*\*                   0.089   -0.252   0.014\*     0.000\*\*

One-sample and two-sample

t

-tests (\*

p

\< 0.05 uncorrected, \*\*

p

\< 0.05, Bonferroni-corrected for 15 tests) including CPZ-equivalent doses as covariate-of-no-interest, for inter-iFC between intrinsic networks in healthy controls and patients with BPD (mean and standard error of Fisher

r

-to-

z

-transformed Pearson's correlation coefficient among network time courses). aDMN, pDMN, anterior and posterior default mode network; aSN, pSN, anterior and posterior salience network; lCEN, rCEN, left and right central executive network.

Interestingly, in our correlation analysis of ICA-derived network time courses we found increased connectivity between the r/lCEN and a/pDMN in HC. This finding might be counterintuitive, since CEN and DMN are usually found anti-correlated (e.g., [@B20]). However, our findings for CEN and DMN sub-networks are perfectly in line with those of [@B3], suggesting that such sub-networks are positively related among each other. This result might be explained by recent findings of [@B59] based on a combination of high-model order spatial and temporal ICA; these authors demonstrated that the DMN can be subdivided into several functionally distinct sub-networks, each with its own characteristic patterns of correlations and anticorrelations with other intrinsic networks.

Finally, the observed global "shift" of inter-iFC among SN and CEN in patients was reflected by an altered CEN/SN-inter-iFC index *r* (**Figure [3B](#F3){ref-type="fig"}**). This ratio reflects the relative intrinsic impact of the CEN in comparison to the SN within the global intrinsic functional architecture of SN, CEN, and DMN. We found a significant difference between *r* (controls) = 1.64 ± 0.80 and *r* (BPD) = 0.99 ± 0.52 with *p* = 0.015 (two-sample *t*-test), potentially indicating a relative shift from cognitive control to emotion processing in patients with BPD (**Figure [3B](#F3){ref-type="fig"}**).

DISCUSSION
==========

The aim of this study was to investigate iFC among SN, DMN, and CEN in patients with BPD. This aim was motivated by previous findings demonstrating that interactions within and between these three networks contribute critically to behavior and emotion regulation; impaired emotion/behavior regulation, in turn, is suggested as an essential property of BPD. In a sample of 14 patients, we found aberrant intra-iFC in all three networks. While patients' inter-iFC of the CEN was generally decreased, only inter-iFC of the SN was increased. In particular, a "balance" index reflecting the relationship of CEN- and SN-inter-iFC across networks was strongly shifted from CEN to SN connectivity in patients. This result provides first preliminary evidence for aberrant intrinsic connectivity among the DMN, SN, and CEN in BPD. Data suggest that patients' impaired emotion/behavior regulation may rely on anomalous iFC among intrinsic networks that is centered on the SN.

ABERRANT INTRA-iFC IN SALIENCE, DEFAULT MODE, AND CENTRAL EXECUTIVE NETWORK IN BPD
----------------------------------------------------------------------------------

In patients, we found increased intra-iFC in the DMN, SN, and CEN with increases covering midline structures such as frontal and parietal cingulate cortices, prefrontal cortices (PFC), parietal lobes, and insular regions (**Figure [2](#F2){ref-type="fig"}**; **Table [4](#T4){ref-type="table"}**). Decreased intra-iFC was found in right hippocampi and in the left dorsolateral frontal cortex (**Figure [2](#F2){ref-type="fig"}**; **Table [4](#T4){ref-type="table"}**). Identified group differences were not due to a disintegration of investigated networks in patients, since basic spatial maps of networks were both largely consistent across groups (**Figure [1](#F1){ref-type="fig"}**; **Table [3](#T3){ref-type="table"}**) and in line with previous findings ([@B12]; [@B3]). Patients' counter-intuitively increased and decreased intra-iFC in intrinsic networks particularly in one and the same network (such as lCEN) has been observed also in other neuropsychiatric disorders such as schizophrenia ([@B44]) or Alzheimer's disease ([@B68]) and -- in line with our findings -- in BPD (for the DMN and CEN; [@B66]); however, the functional significance of the direction of intra-iFC changes in brain disorders is still unclear (e.g., iFC decreases are suggested to reflect connectivity disruptions while iFC-increases might reflect compensatory processes; but also a loss of desynchronization and therefore system complexity may play a role; [@B68]). Previous imaging studies, which explored the neural correlates of impaired self- or emotion-processing in BPD, revealed aberrant task-related activity in areas similar to those of aberrant intra-iFC we found ([@B49]; [@B33]; [@B14]; [@B35]; [@B60]; [@B30]). For example, patients with BPD, who had to engage with emotional stimuli, had aberrant levels of activity in ACC, dorsolateral PFC, and amygdala ([@B49]; [@B35]; [@B30]); the insula was found to be the key region distinguishing BPD patients from HC in a more complex setting of a gambling task ([@B33]); in healthy subjects, self-distancing of negative pictures activates parietal regions overlapping with DMN ([@B36]), while patients with BPD fail to activate the DMN. Furthermore, so far limited literature of resting-state imaging data in BPD supports the spatially widespread pattern of functional changes in BPD. A study using ^18^F-fluorodeoxyglucose-positron emission tomography (FDG-PET) found aberrant brain metabolism in prefrontal and cuneal regions ([@B31]). Importantly, the only rs-fMRI study in BPD reported altered intra-iFC of prefrontal, cuneal, and insular regions within the DMN and CEN ([@B66]), in line with our results. Taken together, our result demonstrates regionally specific iFC changes within DMN, SN, and CEN, which fit spatially previous findings of aberrant activity during tasks involved in emotion- and self-related processing.

ABERRANT INTER-iFC AMONG DMN, SN, AND CEN IN PATIENTS
-----------------------------------------------------

In addition, we found altered inter-iFC among DMN, SN, and CEN in patients (**Figure [3](#F3){ref-type="fig"}**; **Table [5](#T5){ref-type="table"}**). More specifically, we observed an overall decrease of inter-iFC (with only two significant exceptions); this decrease of inter-iFC concerned mainly the CEN while increases were only found in the SN (**Figure [3A](#F3){ref-type="fig"}**; **Table [5](#T5){ref-type="table"}**). The "shift" from a rather evenly spread inter-iFC pattern among the three networks in HC (**Figure [3A](#F3){ref-type="fig"}**) to a SN-centered pattern in patients (**Figure [3A](#F3){ref-type="fig"}**) was further indicated by a strongly reduced CEN-/SN-inter-iFC index (**Figure [3B](#F3){ref-type="fig"}**). The strong impairment of coordinated activity among these networks appears to be in line with a previous EEG study that found strongly impaired gamma-band synchrony in the parietal lobes of BPD patients during a cognitive control task ([@B65]). The most prominent cognitive model of BPD suggests that patients have deficits in emotion regulation due to impaired interactions between (pre-)frontal and limbic areas ([@B56]; [@B45]; [@B42]). This is supported by several above-mentioned task-fMRI studies of either emotion processing ([@B49]; [@B35]) or cognitive control ([@B14]; [@B36]; [@B38]). Since these prefrontal--limbic areas largely overlap with the DMN, CEN, and SN, our results suggest an integrative model of altered intrinsic connectivity between emotion- and cognitive control-relevant intrinsic networks in BPD, which may be related to prefrontal--limbic regulatory deficits. This model implicates that neither system nor brain region alone is responsible for the various and stable behavioral symptoms in BPD. Future studies combining rs-fMRI and task-fMRI are necessary to test explicitly the relationship between aberrant iFC and emotion-evoked activity in BPD.

PARALLELS WITH OTHER NEUROPSYCHIATRIC DISORDERS
-----------------------------------------------

Our result of aberrant iFC among DMN, SN, and CEN is largely consistent with the more general triple network hypothesis of psychopathology ([@B46]). This hypothesis states that psychopathological symptoms are associated with specifically altered coordinated activity across SN, DMN, and CEN; particularly, aberrant SN control function of DMN and CEN might underlie specific mental dysfunctions ([@B52]). For example patients with schizophrenia with and without psychotic symptoms demonstrate distinctive changes of intra- and inter-iFC in the insular SN that are associated with impaired DMN/CEN interactions and positive and negative symptoms of patients ([@B43],[@B44]); in depressive patients, rumination is associated with aberrant coordination of intrinsic SN, DMN, and CEN activity ([@B25]). Concerning BPD, our data suggest that impaired behavior/emotion regulation might be associated with SN-centered inter-iFC reorganization of triple network functional architecture; however, more explicit evidence for such specific link between network interaction changes and behavioral deficits in BPD is necessary (for more detailed discussion of this point see below "limitations"). Furthermore, in comparing among different disorders one has to pay attention to potential confounding effects of psychotropic medication, which might be used in both compared disorders, e.g., antipsychotics in BPD and schizophrenia. Based on these findings, three basic questions about the specificity of aberrant triple network iFC in BPD arise: how specific are iFC changes for distinct psychopathological symptoms such as emotional response style or impulsivity in BPD? Beyond symptoms, how specific are iFC changes for comparisons with other neuropsychiatric disorders? Beyond triple network, which further brain changes outside the triple network such as subcortical or neurochemical changes are critical for distinct symptoms or differences with other disorders? To disentangle such questions, future studies, which may include different psychiatric disorders and brain measures beyond iFC, are necessary.

LIMITATIONS
-----------

First, although comparable with previous studies in BPD, the sample size of our study is small (*n* = 14; e.g., [@B35]; [@B66]; [@B38]). In general, a small sample size reduces the power of effects, and increases the likelihood of false positive results ([@B10]). Therefore the presented results are preliminary and warrant further replication with higher sample sizes. Second, our patient sample is heterogeneous due to gender, comorbidity, and medication status. This heterogeneity is due to clinically based inclusion criteria, which provided a clinical representative patient sample ([@B57]). On the one hand this heterogeneity together with small sample size precluded us to link brain changes with specific behavioral changes; in such groups, the distribution of symptom severity is too heterogeneous to allow for brain--behavior relationship analysis. On the other hand, our results are independent of specific BPD sub-groups, suggesting that observed changes of triple network iFC are a general feature of BPD. Nevertheless, studies in more homogeneous sub-groups of BPD might be helpful to specify aberrant network iFC due to BPD sub-groups. Third, patients of the study were therapeutically treated with psychotropic substances (**Table [2](#T2){ref-type="table"}**). While we did control for antipsychotic medication, we did not control for antidepressant medication because no appropriate numerical procedure (comparable to CPZ conversion) is available for antidepressants. Previously, antidepressant effects on brain activity and functional connectivity have been discussed for the BOLD signal ([@B48]; [@B53]; [@B28]). Although recent studies suggest that antidepressants normalize brain function ([@B4]; [@B21]; [@B28]), we cannot exclude antidepressant medication effects on our results. Future studies of non-medicated patients are necessary. Forth, some limitations concerning the use of ICA to identify ICNs have to be considered. Our selection of a model order 70 was empirical; although a model order of about 75 components seems to be an optimal choice ([@B2]), no clear computational or objective criterion for that number is available. Furthermore, the selection of ICNs of interest from ICA-derived components is intricate, particularly due to subjective bias; to account for this problem, we performed maximally controlled spatial regression analysis of all ICs on ICN templates as previously described ([@B44]), which stem from a previous study using a very similar approach ([@B3]).

CONCLUSION
==========

The current study provides evidence for aberrant iFC within and across DMN, SN, and CEN in patients with BPD. Data suggest a "shift" of inter-network iFC from networks of cognitive control to those of emotion-related activity, potentially reflecting the persistent instability of emotion regulation in patients.
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